Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Ventas's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Ventas's regulatory disclosures and financial reporting.
Reporting person: Robert F. Probst, EVP and CFO of Ventas, Inc. (VTR). Transaction date: 08/04/2025; Form filed: 08/06/2025.
Actions: Probst exercised 29,691 fully vested stock options at an exercise price of $65.45 and sold 29,691 underlying shares pursuant to a Rule 10b5-1 trading plan entered on 02/19/2025. The shares were sold in multiple transactions at prices ranging $68.45–$68.5563 with a weighted average sale price of $68.4917.
Post-transaction position: Beneficial ownership reported as 168,364 shares held directly; 33,591 unexercised options remain (expiration 05/04/2026).
Form 4 Overview: On 07/17/2025, Ventas, Inc. (VTR) director Sumit Roy automatically received two common-stock equivalent grants generated by dividend-equivalent credits: 49.07 units under the Non-Employee Directors’ Cash Compensation Deferral Plan and 78.961 units under the Non-Employee Directors’ Equity Award Deferral Program, totaling 128.031 shares. The grants were valued at the 07/17/2025 closing price of $65.37 and are payable solely in common stock per the respective plan terms.
Following the credits, Roy’s direct beneficial ownership rose to 20,770.297 shares. No open-market transactions, sales, or derivative exercises were reported, and Table II shows no derivative positions. Because the award is routine, non-cash and represents a de-minimis percentage of Ventas’ outstanding shares, it is unlikely to have an immediate impact on share supply or market sentiment.
Form 144 filing: A beneficial owner named Robert F. Probst has notified Ventas, Inc. (VTR) of his intent to sell up to 29,493 common shares through Merrill Private Wealth on the NYSE around 07/21/2025. At the reference price used in the filing, the block is valued at ≈ $1.95 million.
The notice also lists completed sales by the same seller during the last three months: 69,592 shares on 05/21/25, 17,374 shares on 05/27/25, 168,318 shares on 07/14/25, and 4,098 shares on 07/18/25, for combined gross proceeds of ≈ $16.86 million. Adding the proposed sale, the cumulative disposition reaches 288,875 shares.
With Ventas reporting 451.3 million shares outstanding, the new transaction equals roughly 0.0065 % of total shares, implying minimal dilution or market‐moving impact. The standard Rule 144 certification affirms the seller holds no undisclosed material adverse information.